Hasselt, Belgium & Leiden, The Netherlands – April 7th, 2026 We are proud to highlight a new strategic collaboration between our member, simAbs, and Ardent… Read More »simAbs and Ardent Biopharma Announce Strategic Partnership to Advance Next-Generation Biosimilar Manufacturing
SwiftPharma and Benno Therapeutics are taking a next step in their collaboration by establishing a dedicated R&D presence in Leuven. While SwiftPharma remains headquartered at… Read More »SwiftPharma and Benno Therapeutics expand R&D footprint with new collaborative site in Leuven
Authors: Lara Kelchtermans, Katrien Geerts, Cuong Thi Pham, Vanshika Malviya, Winston Chiu, Carolien De Keyzer, Elias Broeckhoven, Johan Neyts, Susan Schlenner, Yeranddy A. Alpizar & Kai Dallmeier Journal: Nature immunologyPublished: 25 March 2026DOI: https://doi.org/10.1038/s41590-026-02478-7 Abstract Recurring outbreaks… Read More »CD4+ T cell-mediated immunity protects from VSV-SUD lethal challenge in a mouse model of Sudan virus infection
Today, Sagitta Biotech announced positive preclinical results for its Flu vaccine candidate, demonstrating robust immunogenicity and efficacy in mice. These findings represent a significant development… Read More »Sagitta Biotech Announces Positive Preclinical Results, Marking a Key Milestone in Platform development and Pipeline Advancement
Nantes, France and Geneva, Switzerland, March 9, 2026 – Naobios, a Contract Development and Manufacturing Organization (CDMO) providing bioprocess development and GMP production of clinical batches… Read More »Naobios and SGS partner to manufacture Respiratory Syncytial Virus (RSV) challenge agent
SimAbs has successfully raised €5 million in a Series A funding round, marking an important milestone in the company’s mission to transform the way antibodies… Read More »SimAbs raises €5M Series A to scale continuous antibody manufacturing
About this white paper This white paper is an evidence-based call to action for Belgian policymakers on the implementation of tools required to eliminate HPV-related… Read More »Advancing public health: a roadmap to the implementation of tools required to eliminate HPV-related cancers and diseases in Belgium by 2030
Authors: Nicky de Vrij, Elise Pepermans, Louise Laurijssen, Thao-Thy Pham, Lauren Thijs, Kurt Boonen, Kadrie Ramadan, Ilse Maes, Yetemwork Aleka, Mekibib Kassa, Tigist Mekonnen, Mezgebu… Read More »Immunopeptidomics of cutaneous leishmaniasis patients reveals the natural antigenic landscape
Hannah R. Volkman , Leonie de Munter, Jennifer L. Nguyen, Thao M. P. Tran, Marianna itratza,Cátia Marques, Laura Choi, Srinivas Valluri, Jingyan Yang, Andrés Antón, Irma… Read More »Durability of the BNT162b2 XBB:1.5-adapted vaccine against JN.1 hospitalisation in Europe, October 2023 to August 2024: A test-negative case-control study using the id.DRIVE platform
Leuven, Belgium and Zeist, The Netherlands, November 19, 2025 – P95 and Julius Clinical today announced that they have merged to form a leading global, full-service… Read More »P95 and Julius Clinical merge to form global, science-led CRO delivering integrated clinical development and real-world evidence
